Resultados de la búsqueda 981-990 of 5912 for Phase

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with CD22 positive B acute lymphoblastic leukemia that has ...

  2. Hematología - Ensayos clínicos

    This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) in participants with relapsed or refractory ...

  3. Oncología (médica) - Ensayos clínicos

    This phase I trial studies the best dose and side effects of recombinant vesicular stomatitis virus carrying the human NIS and IFN beta genes (VSV-hIFNbeta ...

  4. Oncología (médica) - Ensayos clínicos

    This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) in participants with relapsed or refractory ...

  5. Oncología (médica) - Ensayos clínicos

    This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric and ...

  6. Oncología (médica) - Ensayos clínicos

    ... phase. A Feasibility Study To Evaluate The Safety Of The TheraSphere Glioblastoma (GBM) Device In Patients With Recurrent GBM. Jacksonville, Fla. The purpose ...

  7. Oncología (médica) - Ensayos clínicos

    Scottsdale/Phoenix, Ariz., Rochester, Minn. This phase II trial studies how well sapanisertib works in treating patients with pancreatic neuroendocrine ...

  8. Oncología (médica) - Ensayos clínicos

    ... Phase 2 dose (RP2D), as well as to evaluate preliminary effectiveness. Evaluating Intestinal Microbiome and Immune Function in Lymphoma. Rochester, Minn. The ...

  9. Oncología (médica) - Ensayos clínicos

    This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) in participants with relapsed or refractory ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to determine the maximum tolerated dose (MTD) and schedule and/or a recommended Phase 2 dose (RP2D) and schedule of KTX-1001 ...